Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine plus primaquine for Plasmodium vivax malaria in Southern Ethiopia
PACTR202606816992571Completed
- Sponsor
- Dilla University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chloroquine and primaquine in vivax malaria, sponsored by Dilla University. Primary endpoint: Adequate clinical and parasitological response. Started Jan 2024; status: completed.
02
Drugs
chloroquineprimaquine
03
Conditions
vivax malaria
Beyond the preview
Go deeper on PACTR202606816992571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606816992571.